BMRN

NASDAQ · Biotechnology

Biomarin Pharmaceutical Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$55.90

+1.21 (+2.21%)

Analyst Consensus

Strong Buy

Analysts

Very High

Coverage

Buy 27 79%

Hold 7 21%

Sell 0 0%

Price Target

Analyst Price Target +126.2% upside

Low Target $89.21

Average Target $126.44

High Target $194.19

Current Price $55.90

Current
$55.90

Target
$126.44

$89.21 $126.44 avg $194.19

Scenario Analysis

Bear Case

$89.21

59.6%

Low target

Base Case

$126.44

+126.2%

Avg target

Bull Case

$194.19

+247.4%

High target

Risk/Reward

4.2x

Highly favorable

Price in Context

52-Week High

$66.28

-15.7% from high

52-Week Low

$49.26

+13.5% from low

50-Day SMA

$57.48

-2.7% vs SMA

200-Day SMA

$56.51

-1.1% vs SMA

RSI (14)

80.7

Overbought

Target vs 52W High

$126.44

+90.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+12.0%
AMGN Amgen Inc	Hold	44	50%	$190.87	-44.6%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.1%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.5%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-31.2%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-37.5%